Gibson, Dunn & Crutcher LLP Advised KKR in the Closing of its Investment in Biosynth Carbosynth and Biosynth Carbosynth’s Acquisition of Vivitide

March 17, 2022

Gibson, Dunn & Crutcher LLP advised KKR in the closing of its investment in Biosynth Carbosynth as well as in Biosynth Carbosynth’s acquisition of Vivitide. More information can be found in the news announcement.

The Gibson Dunn team was led by partner Wim De Vlieger and included partners Till LeFranc and Branden Berns and associates Jakob Egle, Bansaree Shah, Romain Tourenne, Jena Pollock and Jordan Holsinger.

Partner Eric Sloan and associate James Jennings advised on tax aspects, and partner Sean Feller advised on benefits. Partner Ahmed Baladi and associates Clémence Pugnet and Reid Rector advised on data protection aspects. Partner Marian Lee and associate Sarah Erickson advised on regulatory aspects. Partner Peter Modlin advised on environmental aspects. Partner Karen Spindler, of counsel Todd Trattner and associates David Glandorf and Erin Wall advised on IP aspects. Associate Nicole Kim advised on financing. Associate Stephanie Roualet advised on real estate aspects.